News

India on Track to Become Global Pharma Leader, Targets $1 Trillion Industry by 2047

Currently valued at $55 billion, the industry is projected to grow to $130 billion by 2030 and $450 billion by 2047, fueled by innovation, affordability, and global demand for high-quality medicines.

• By Newsdesk
• New Delhi
• Nov 28, 2024

News

India’s pharmaceutical sector is on a trajectory of unprecedented growth, aiming to solidify its position as the ‘Pharmacy of the World’ and achieve a $1 trillion valuation by 2047. Currently valued at $55 billion, the industry is projected to grow to $130 billion by 2030 and $450 billion by 2047, fueled by innovation, affordability, and global demand for high-quality medicines.

Renowned for its pivotal role in COVID-19 vaccine distribution, the Indian pharma industry is also recognized as the ‘Healers of the World.’ With exports contributing $27.85 billion, India supplies affordable medications to over 200 countries, cementing its position as a vital player in the global healthcare ecosystem.

Experts attribute the sector's rapid expansion to advancements in biologics, specialty generics, and the integration of artificial intelligence (AI) technologies. India’s cost-effective manufacturing processes—30-35% cheaper than those in the US and Europe—and significantly lower R&D expenses, 87% below developed markets, have further strengthened its global competitiveness.

Speaking at the CPHI & PMEC India Expo in Noida, industry leaders highlighted the sector’s achievements and future potential. The three-day event, featuring over 2,000 exhibitors and 50,000 visitors from more than 120 countries, showcased innovations in pharma machinery, packaging, and biopharmaceuticals.

Yogesh Mudras, Managing Director of Informa Markets in India, emphasized the sector's global standing, stating, “India ranks third in pharmaceutical production by volume and 14th by value, contributing 1.72% to the nation’s GDP. As one of the top 12 global biotechnology hubs and the third-largest in the Asia-Pacific region, India is a cornerstone of the global pharmaceutical industry.”

With a robust talent pool and a strong focus on research and development, India is well-positioned to lead both the production and innovation fronts of the pharmaceutical sector, driving its vision to become a trillion-dollar industry by mid-century.